In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Antisense Therapeutics Limited Balance Sheet Statement - Assets

As of 30 Jun 2021, The total current assets of Antisense Therapeutics Limited (ASX:ANP) was around $6,698,599 which consisted of $6,020,403 of Cash, no Inventory and $601,254 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$6.02M
Current assets
$6.7M
Total assets
$7M

The latest balance sheet of Antisense Therapeutics Limited also showed $302,004 of Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $7,000,603.

Antisense Therapeutics Limited Balance Sheet Statement - Liabilities

ANP's latest annual results shows the balance sheet has $157,073 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $4,577 of Other Current liabilities and $1,045,551 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$157.07k
Current liabilities
$1.05M
Total liabilities
$1.27M

As per the 30 Jun 2021's annual report of Antisense Therapeutics Limited, the total liabilities were $1,273,070.

ANP Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Antisense Therapeutics Limited showed the total stock holder equity was $5,727,533 which consisted of $77,033,694 of Common stocks, $-75,097,579 of Retained earnings and $3,791,418 of Other stock holder equity.

ANP Balance Sheet Statement History

Following table shows the history of balance sheet for Antisense Therapeutics Limited (ANP).

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Cash6.02M4.06M2.9M1.9M
Net Receivables601.25k689.32k606.47k331.16k
Inventory----
Total Current Assets6.7M5.21M3.7M4.79M
Property Plant Equipment302k138.12k2.3k7.67k
Good Will----
Intangible Assets----
Other Assets----
Deferred Long Term Asset Charges----
Total Assets7M5.35M3.7M4.8M
Accounts Payable157.07k107.87k227.13k103.75k
Short/Long Term Debt----
Other Current Liabilities4.58k4.58k4.58k4.58k
Long Term Debt----
Other Liabilities117-9.08k-
Total Current Liabilities1.05M798.54k879.75k580.86k
Total Liabilities1.27M821.23k888.84k580.86k
Common Stock77.03M69.15M63.94M62.41M
Retained Earnings-75.1M-67.04M-61.13M-58.18M
Treasury Stock3.79M2.42M--
Other Stockholder Equity3.79M2.42M--
Total Stockholder Equity5.73M4.53M2.81M4.22M
Net Tangible Assets5.73M4.53M2.81M4.22M

Antisense Therapeutics Limited (ASX:ANP) Balance Sheet Statement FAQ

1. How much Cash Antisense Therapeutics Limited has on their balance sheet?

As of 30 Jun 2021, Antisense Therapeutics Limited (ASX:ANP) has $6,020,403 of Cash.

2. What's the long term debt of Antisense Therapeutics Limited?

As per the latest Balance sheet of Antisense Therapeutics Limited (ASX:ANP), it has no Long term debt.

3. How much share holder equity does Antisense Therapeutics Limited has?

The Antisense Therapeutics Limited (ASX:ANP)'s balance sheet shows that it has $5,727,533 of Total stock holder equity.